ArticleJournal of the Endocrine Society2017
Effects of Linagliptin on Pancreatic
Yanqing Zhang, Genevieve E Fava, Meifen Wu, Wynn Htun, Thomas Klein, Vivian A Fonseca, Hongju Wu
Open access · goldAbstract read
In one paragraphArticle in Journal of the Endocrine Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors at 2 institutions in 2 countries.
Yanqing ZhangDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Genevieve E FavaDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Meifen WuDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Wynn HtunDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Thomas KleinBoehringer-Ingelheim Pharma GmbH & Co. KG, Biberach 88597, Germany.
Vivian A FonsecaDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Hongju WuDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Tulane University · USBoehringer Ingelheim (Germany) · DE
Funding
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness studyU01DK098246 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI KRAUSE-STEINRAUF, HEIDI, LACHIN, JOHN M · 2012 to 2022
$238.9MTracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1MImproving Islet Transplantation Outcome With Akt1R01DK081463 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WU, HONGJU · 2009 to 2013
$1.6MPax4-induced alpha-to-beta cell conversionR01DK107412 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI WU, HONGJU · 2016 to 2018
$1.0MPotential of Urinary AGT as a Novel Biomarker for Intrarenal RAS Activity in T1DMR21DK094006 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI NAVAR, LUIS GABRIEL · 2012 to 2013
$407kNIDDK NIH HHS R01 DK081463NIDDK NIH HHS R01 DK107412NIDDK NIH HHS R21 DK094006NIDDK NIH HHS U01 DK098246NIGMS NIH HHS U54 GM104940
6 · The paper itselfAbstract
The dipeptidyl peptidase-4 inhibitor linagliptin promotes
Indexed as
diabetesDPP4 inhibitorGLP-1linagliptinα cells
Identifiers
PMID29264448
PMCPMC5686619
OpenAlexW2751487777
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390